DEBASMITA SAHA

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (68)

• Table S3 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337951
  +Save
• Supplementary Data - Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337972
  +Save
• Supplementary Figures and Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337969
  +Save
• Supplementary Figures and Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337969.v1
  +Save
• Table S1 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337966.v1
  +Save
• Table S1 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337966
  +Save
• Table S10 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337963.v1
  +Save
• Table S10 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337963
  +Save
• Table S11 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337960.v1
  +Save
• Table S12 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
  2024 DOI: 10.1158/1535-7163.25337957
  +Save